Tranexamic Acid vs Hydroquinone for Melasma: A Complete Comparison Guide | Korean Plastic Surgery

Reviewed for accuracy against: Korean Society of Plastic and Reconstructive Surgeons (KSPRS) guidance and KHIDI medical-tourism materials. Written by the Korean Plastic Surgery international-patient editorial desk. Last reviewed July 2026.

Tranexamic acid vs hydroquinone for melasma is not strictly either-or: hydroquinone is the long-established topical that suppresses melanin production, while tranexamic acid — taken orally or applied topically — targets the vascular and inflammatory signals that drive melasma. Many Korean dermatology clinics use them at different stages rather than choosing one forever.

Melasma is chronic and relapse-prone, so the realistic goal is control, not a guaranteed cure. Below is how each agent works and how clinicians weigh them.

How Hydroquinone Works

Hydroquinone inhibits tyrosinase, the enzyme that converts tyrosine into melanin, reducing pigment output at the source. It remains one of the most evidence-supported topicals for melasma in the dermatology literature indexed on PubMed. Because prolonged, unsupervised use carries risks such as irritation and, rarely, exogenous ochronosis, Korean clinics typically prescribe it in supervised courses rather than indefinitely.

How Tranexamic Acid Works

Tranexamic acid interrupts the plasminogen pathway, dampening the vascular and inflammatory triggers that stimulate melanocytes. This makes it useful for the stubborn, relapse-prone component of melasma that pure pigment blockers do not fully address. It is available as an oral course or a topical, and its systemic use requires screening because it is an antifibrinolytic and is not appropriate for everyone.

Head-to-Head: Strengths and Limits

Hydroquinone strengths: strong first-line depigmenting effect, decades of clinical use, widely available.

Hydroquinone limits: best used in supervised cycles, potential irritation, not for indefinite use.

Tranexamic acid strengths: addresses vascular/relapse component, useful when topicals plateau, oral or topical options.

Tranexamic acid limits: oral form needs medical screening (clotting-risk history is a contraindication), effect is gradual.

Why Korean Clinics Often Combine Rather Than Choose

A common Korean protocol pairs a supervised hydroquinone course with oral or topical tranexamic acid and strict daily photoprotection, sometimes adding low-fluence laser only after pigment is calmer. The logic is that hydroquinone reduces existing pigment while tranexamic acid lowers the drive to make more — attacking two mechanisms at once. This layered approach is individualized after diagnosis.

The Non-Negotiable: Sun Protection

Neither agent holds results without daily broad-spectrum sunscreen and UV avoidance, because ultraviolet and visible light reactivate melasma. Korean clinicians treat photoprotection as the foundation of every plan; without it, both drugs underperform. Our guide to reading cosmetic ingredient labels helps you pick a suitable daily sunscreen.

Safety and Who Should Be Cautious

Pregnant or breastfeeding patients, those with clotting disorders or a thrombosis history, and anyone on certain medications should disclose this before oral tranexamic acid. Hydroquinone should be used exactly as prescribed and paused if significant irritation occurs. A board-certified dermatologist should supervise both, consistent with KHIDI patient-safety guidance for medical travelers.

Frequently Asked Questions

Can I use both at the same time?

Often yes, under supervision — they act on different pathways — but the combination and duration should be set by a clinician after examining your skin.

How fast will I see results?

Melasma responds slowly; visible improvement over 8–12 weeks is typical, and maintenance is usually needed.

Is oral tranexamic acid safe for everyone?

No. It is contraindicated in people with clotting risk and requires medical screening first.

Will laser alone fix melasma faster?

Aggressive laser can worsen melasma. Korean clinics usually stabilize pigment medically before considering low-fluence laser.

The Bottom Line

Hydroquinone is the front-line pigment blocker; tranexamic acid manages the relapse-prone vascular component. For most melasma, a supervised combination plus disciplined sun protection outperforms either drug alone. Consult a board-certified dermatologist before starting.

Related Reading: How to Read Cosmetic Ingredient Labels · Retinol vs Tretinoin vs Adapalene: A Prescription Guide · Skin Barrier Repair Science Explained

Sources & Further Reading: KHIDI (Korea Health Industry Development Institute) · Korean Society of Plastic and Reconstructive Surgeons (KSPRS) · PubMed peer-reviewed literature

Medical disclaimer: This article is general information reviewed against Korean clinical society guidance and is not a substitute for an individualized consultation with a board-certified specialist. Outcomes, recovery, and risks vary by person; no result is guaranteed.